 |
||||||||||||||||||
|
Speakers The speaker panel for the Phacilitate Cell & Gene Therapy Forum 2010 is now almost complete. Amongst the high profile speakers who have already confirmed their participation are: Dr Celia M. Witten, Director, Office of Cellular, Tissue & Gene Therapies (OCTGT), CBER, US FDA Dr Mitchell Gold, President & CEO, Dendreon Corporation Dr Chuck Wilson, Vice President, Global Head of Strategic Alliances, Novartis Institutes for BioMedical Research Stephen Potter, Senior Vice President, Corporate & Business Development, Genzyme Corporation Dr John McNeish, Executive Director, Regenerative Medicine, Pfizer, Inc Dr Alain Vertès, Global Alliance Director, Roche Pharma Partnering Dr. C. Randal Mills, President & CEO, Osiris Therapeutics, Inc Stephen M. Kelsey, MD, Executive Vice President & Chief Medical Officer, Oncology, Geron Corporation Gil Beyen, Co-founder & Managing Director (CEO), TiGenix NV Leslie Wolfe, PhD, Vice President, Technology Development, Cellular Therapies, Genzyme Dr Christian K. Schneider, Head of Division of EU Cooperation/Microbiology, Paul-Ehrlich-Institut & Chair, EMEA Committee for Advanced Therapies (CAT) Andrea Hunt, Vice President, Regenerative Medicine, Baxter Healthcare Corporation George W. Dunbar, Chairman of the Board, Aastrom Biosciences Dr Brian A. Meltzer, Senior Director, RedScript Ventures, Johnson & Johnson Corporate Development Dr Claudio Bordignon, President & CEO, MolMed SpA Elona Baum, Esq, General Counsel, California Institute for Regenerative Medicine (CIRM) Dr Sam Wadsworth, Group Vice President, Translational Research, Genzyme Corporation Dr Alex Barkas, Managing Director, Prospect Venture Partners Dr Jacqueline Corrigan-Curay, Acting Director, Office of Biotechnology Activities, National Institutes of Health James M. Wilson, MD, PhD, Head, Gene Therapy Program, Department of Pathology & Laboratory Medicine, University of Pennsylvania, School of Medicine Edward Lanphier, President & CEO, Sangamo BioSciences, Inc Robert C. Moen, MD, PhD, President & CEO, Copernicus Therapeutics Dr Robert A. Preti, President & Chief Scientific Officer, Progenitor Cell Therapy, LLC Mike Rice, President, CEO & Chairman, BioLife Solutions, Inc Mark E. Saad, CFO, Cytori Therapeutics, Inc David Smith, Head of Global Therapeutic Cell Solutions, Lonza Dr Debra S. Grega, Executive Director, Center for Stem Cell & Regenerative Medicine, National Center for Regenerative Medicine Joao Siffert, MD, Chief Medical Officer, Ceregene Kenneth C. Aldrich, Chairman & CEO, International Stem Cell Corporation & Managing Director, Convergent Investors, LLC Dr Chris Holloway, Group Director of Regulatory Affairs & CSO, ERA Consulting Group Prannath Marrott, FRACP, MRCP, Senior Vice President, Clinical Development & Regulatory Affairs, AnGes, Inc Michael J. Werner, Partner, Holland & Knight Gary J. Kurtzman, MD, Vice President & Managing Director, Life Sciences Dr E. Edward Baetge, Senior Vice President & CSO, Novocell Dr Jane Lebkowski, Senior Vice President & CSO, Regenerative Medicine, Geron Corporation Gregg Sando, CEO, Cell Medica Limited Ed Field, President & COO, Aldagen Dr David Urdal, Chief Scientific Officer, Dendreon Corporation Paul J. Schmitt, Managing Director, Novitas Capital Dr Joshua M. Hare, Professor of Medicine, Director of the Interdisciplinary Stem Cell Institute, Miller School of Medicine, University of Miami Sheila A. Mikhail, Chief Executive Officer, NanoCor Therapeutics, Inc Kristin Comella, Vice President of Research & Corporate Development, Bioheart, Inc Dr Jon Rowley, Director of Cell Therapy R&D, Lonza Biosciences Eric Faulkner, Senior Director, US Market Access & Reimbursement, RTI Health Solutions Dr Geert-Jan Mulder, General Partner, Forbion Capital Partners Dr Gary J. McGarrity, Executive Vice President of Scientific & Clinical Affairs, VIRxSYS Corporation Dr Joyce Frey-Vasconcells, Executive Director, PharmaNet Dr Ram Mandalam, President & CEO, Cellerant Therapeutics, Inc Dr Gabor M. Rubanyi, Chief Scientific Officer, Cardium Therapeutics Dr Denise K. Gavin, Division of Cellular & Gene Therapies (DCGT), Office of Cellular, Tissue & Gene Therapies (OCTGT), CBER, US FDA Dr Scott R. Burger, Principal, Advanced Cell & Gene Therapy Professor Sander Van Deventer, CSO, AMT BV Dr Dirk Büscher, Vice President of Research & Development, Cellerix Dr Andrew L. Pecora, Chairman of the Board, Amorcyte Dr Sonia Skarlatos, Deputy Director, Division of Cardiovascular Sciences, National Heart, Lung & Blood Institute, NIH Dr Dan Gincel, Director, Maryland Stem Cell Research Fund, Maryland Technology Development Corporation (TEDCO) Dr Samuel G. Jacobson, Professor of Ophthalmology & Director, Center for Hereditary Retinal Degenerations & Retinal Function Department, University of Pennsylvania School of Medicine Aby J. Mathew, PhD, Senior Director, Strategic Relations & Senior Scientist, Dr Doug Jolly, Executive Vice President of Research & Product Development, Tocagen, Inc Dr Philip D. Gregory, D. Phil, Chief Scientific Officer, Sangamo BioSciences, Inc Jai Pal Singh PhD, Chief Scientific Officer, Vice President of Research, St Joseph’s Translational Research Institute Robert Shaw, Technical Director, Ark Therapeutics Dr Janneke Meulenberg, CEO, ORCA Therapeutics Dr Wilfried Dalemans, CTO & Vice President, Regulatory Affairs, TiGenix NV Professor Alan Boyd, Honorary Professor, College of Medical & Dental Sciences, University of Birmingham Medical School & Managing Director, alan boyd consultants ltd Dr Dara Kraitchman, Associate Professor, Russell H. Morgan Department of Radiology & Radiological Science, Johns Hopkins School of Medicine Jack Harvey, MPH, Director of Manufacturing, Pervasis Therapeutics, Inc Dr Liz Bui, Director, Intellectual Property & Corporate Development, Novocell Brian S. Hampson, Senior Engineering Fellow, Aastrom Biosciences, Inc Visit this page again soon to see who else you will be able to hear from – and meet – in Washington, DC this coming January.
©Copyright Phacilitate Limited 2009
|
 Click here to download the previous three Cell & Gene Therapy Forum Main Announcements
|
||||||||||||||||
